ClinicalTrials.Veeva

Menu

Detection of COVID-19 in Saliva Collection (SALICOV)

C

Centre Hospitalier Universitaire, Amiens

Status

Completed

Conditions

Sars-CoV2
Nasopharyngeal Sample
Saliva Collection
RT-PCR

Study type

Observational

Funder types

Other

Identifiers

NCT04386551
PI2020_843_0045

Details and patient eligibility

About

Since December 2019, the world has faced a pandemic of COVID-19, an infectious disease caused by SARS-CoV-2, a virus that emerged in China. The reference diagnosis is based on the search for the SARS-COV-2 genome in the nasopharyngeal sample.

Carrying out this sample requires the competence of a healthcare professional and presents some inconveniences for the tested patient. Because saliva collection is simple, non-invasive, painless and inexpensive, and can be performed by poorly trained personnel, it could be an alternative to the reference nasopharyngeal sample. SARS-CoV2 detection in human saliva could be a potential diagnosis of COVID infection.

Enrollment

501 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient hospitalized at the Amiens CHU in a COVID-19 unit
  • patient seen as outpatient in the area of infectious pathologies for COVID-19 infection

Exclusion criteria

  • Patients under 18
  • patients under guardianship or curators

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems